Marc Frahm
Stock Analyst at TD Cowen
(4.91)
# 235
Out of 4,556 analysts
398
Total ratings
57%
Success rate
26.6%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Marc Frahm
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| RVMD Revolution Medicines | Maintained: Buy | n/a | $183.57 | - | 25 | Jul 2, 2026 | |
| INCY Incyte | Maintained: Buy | $124 | $116.72 | +6.24% | 71 | Jun 22, 2026 | |
| AGIO Agios Pharmaceuticals | Maintained: Buy | n/a | $36.00 | - | 24 | Jun 16, 2026 | |
| DMRA Damora Therapeutics | Maintained: Buy | n/a | $30.14 | - | 2 | Jun 11, 2026 | |
| CGEM Cullinan Therapeutics | Maintained: Buy | n/a | $17.86 | - | 26 | Jun 10, 2026 | |
| CRDF Cardiff Oncology | Maintained: Hold | n/a | $0.85645 | - | 16 | Jun 4, 2026 | |
| ACRV Acrivon Therapeutics | Maintained: Buy | n/a | $1.68 | - | 12 | May 14, 2026 | |
| SANA Sana Biotechnology | Maintained: Buy | n/a | $3.15 | - | 14 | May 11, 2026 | |
| NKTR Nektar Therapeutics | Reiterated: Buy | n/a | $68.82 | - | 2 | May 8, 2026 | |
| PBYI Puma Biotechnology | Maintained: Hold | $5 | $8.22 | -39.17% | 11 | May 8, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | $15 | $16.87 | -11.06% | 19 | May 8, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $15.64 | - | 18 | May 8, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $49.28 | - | 23 | May 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $1.83 | - | 15 | May 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $6.92 | - | 13 | May 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $23.42 | - | 16 | May 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $111.37 | - | 22 | May 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $8.67 | - | 10 | Nov 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $0.033 | n/a | 19 | Nov 14, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $3.71 | n/a | 8 | Jan 12, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $105.04 | n/a | 10 | Jan 26, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $150,000.00 | n/a | 6 | Mar 22, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | n/a | $3.10 | n/a | 1 | Mar 2, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $1.86 | n/a | 3 | Aug 5, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Hold | n/a | $39.49 | n/a | 5 | Feb 26, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $1,164.08 | n/a | 1 | Jan 7, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $321.53 | n/a | 6 | Dec 4, 2018 |
Revolution Medicines
Jul 2, 2026
Maintained: Buy
Price Target: n/a
Current: $183.57
Upside: -
Incyte
Jun 22, 2026
Maintained: Buy
Price Target: $124
Current: $116.72
Upside: +6.24%
Agios Pharmaceuticals
Jun 16, 2026
Maintained: Buy
Price Target: n/a
Current: $36.00
Upside: -
Damora Therapeutics
Jun 11, 2026
Maintained: Buy
Price Target: n/a
Current: $30.14
Upside: -
Cullinan Therapeutics
Jun 10, 2026
Maintained: Buy
Price Target: n/a
Current: $17.86
Upside: -
Cardiff Oncology
Jun 4, 2026
Maintained: Hold
Price Target: n/a
Current: $0.85645
Upside: -
Acrivon Therapeutics
May 14, 2026
Maintained: Buy
Price Target: n/a
Current: $1.68
Upside: -
Sana Biotechnology
May 11, 2026
Maintained: Buy
Price Target: n/a
Current: $3.15
Upside: -
Nektar Therapeutics
May 8, 2026
Reiterated: Buy
Price Target: n/a
Current: $68.82
Upside: -
Puma Biotechnology
May 8, 2026
Maintained: Hold
Price Target: $5
Current: $8.22
Upside: -39.17%
May 8, 2026
Rated: Hold
Price Target: $15
Current: $16.87
Upside: -11.06%
May 8, 2026
Maintained: Buy
Price Target: n/a
Current: $15.64
Upside: -
May 7, 2026
Maintained: Buy
Price Target: n/a
Current: $49.28
Upside: -
May 7, 2026
Maintained: Buy
Price Target: n/a
Current: $1.83
Upside: -
May 7, 2026
Maintained: Buy
Price Target: n/a
Current: $6.92
Upside: -
May 7, 2026
Reiterated: Buy
Price Target: n/a
Current: $23.42
Upside: -
May 5, 2026
Maintained: Buy
Price Target: n/a
Current: $111.37
Upside: -
Nov 13, 2025
Maintained: Buy
Price Target: n/a
Current: $8.67
Upside: -
Nov 14, 2024
Maintained: Buy
Price Target: n/a
Current: $0.033
Upside: n/a
Jan 12, 2024
Rated: Hold
Price Target: n/a
Current: $3.71
Upside: n/a
Jan 26, 2023
Downgraded: Hold
Price Target: n/a
Current: $105.04
Upside: n/a
Mar 22, 2021
Downgraded: Hold
Price Target: n/a
Current: $150,000.00
Upside: n/a
Mar 2, 2021
Initiated Coverage: Buy
Price Target: n/a
Current: $3.10
Upside: n/a
Aug 5, 2020
Maintained: Buy
Price Target: n/a
Current: $1.86
Upside: n/a
Feb 26, 2019
Initiated Coverage: Hold
Price Target: n/a
Current: $39.49
Upside: n/a
Jan 7, 2019
Downgraded: Hold
Price Target: n/a
Current: $1,164.08
Upside: n/a
Dec 4, 2018
Maintained: Buy
Price Target: n/a
Current: $321.53
Upside: n/a